These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8374627)

  • 1. Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children.
    Eskola J; Takala AK; Käyhty H
    Curr Opin Pediatr; 1993 Feb; 5(1):55-9. PubMed ID: 8374627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
    Heath PT
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilus influenzae type B conjugate vaccines.
    Force RW; Lugo RA; Nahata MC
    Ann Pharmacother; 1992 Nov; 26(11):1429-40. PubMed ID: 1477450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Haemophilus influenzae type b disease.
    Santosham M
    Vaccine; 1993; 11 Suppl 1():S52-7. PubMed ID: 8447177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines.
    Mohle-Boetani JC; Ajello G; Breneman E; Deaver KA; Harvey C; Plikaytis BD; Farley MM; Stephens DS; Wenger JD
    Pediatr Infect Dis J; 1993 Jul; 12(7):589-93. PubMed ID: 8346003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
    Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New vaccines against Haemophilus influenzae type b.
    Shapiro ED
    Pediatr Clin North Am; 1990 Jun; 37(3):567-83. PubMed ID: 2190140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Haemophilus influenzae type b vaccines in Massachusetts children 18 to 59 months of age.
    Loughlin AM; Marchant CD; Lett S; Shapiro ED
    Pediatr Infect Dis J; 1992 May; 11(5):374-9. PubMed ID: 1630857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.
    Takala AK; Eskola J; Leinonen M; Käyhty H; Nissinen A; Pekkanen E; Mäkelä PH
    J Infect Dis; 1991 Nov; 164(5):982-6. PubMed ID: 1940479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type b. Conjugate vaccines for use in infants and children.
    Hanna JN; Steven ID; Plant AJ
    Aust Fam Physician; 1993 Jun; 22(6):1015-7, 1020-1. PubMed ID: 8338447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
    J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use.
    Black SB; Shinefield HR; Fireman B; Hiatt R
    J Infect Dis; 1992 Jun; 165 Suppl 1():S139-43. PubMed ID: 1588149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children.
    Takala AK; Santosham M; Almeido-Hill J; Wolff M; Newcomer W; Reid R; Käyhty H; Esko E; Mäkelä PH
    Pediatr Infect Dis J; 1993 Jul; 12(7):593-9. PubMed ID: 8346004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilus influenzae type b vaccines: history, choice and comparisons.
    Decker MD; Edwards KM
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S113-6. PubMed ID: 9781742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus b conjugate vaccines.
    Vella PP; Ellis RW
    Biotechnology; 1992; 20():1-22. PubMed ID: 1600377
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
    Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
    Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum antibodies against haemophilus influenzae type b and tetanus at 2.5 years of age: a follow-up of 2 different regimens of infant vaccination.
    Carlsson RM; Claesson BA; Lagergård T; Käyhty H
    Scand J Infect Dis; 1996; 28(5):519-23. PubMed ID: 8953685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.